GIST - GASTROINTESTINAL STROMAL TUMOR
Clinical trials for GIST - GASTROINTESTINAL STROMAL TUMOR explained in plain language.
Never miss a new study
Get alerted when new GIST - GASTROINTESTINAL STROMAL TUMOR trials appear
Sign up with your email to follow new studies for GIST - GASTROINTESTINAL STROMAL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo trial aims to control advanced stomach cancer
Disease control Not yet recruitingThis study is testing whether adding an experimental drug called KQB198 to the standard treatment imatinib is safe and more effective for people with advanced gastrointestinal stromal tumors (GIST). It will involve about 46 patients who are starting their first treatment for canc…
Matched conditions: GIST - GASTROINTESTINAL STROMAL TUMOR
Phase: PHASE2 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
New drug trial offers hope for advanced stomach cancer patients Who've run out of options
Disease control Not yet recruitingThis study is testing an experimental drug called NB003 for people with advanced gastrointestinal stromal tumors (GIST) that have stopped responding to standard medications. The trial has two parts: one compares NB003 against an existing drug for patients who need third-line trea…
Matched conditions: GIST - GASTROINTESTINAL STROMAL TUMOR
Phase: PHASE2, PHASE3 • Sponsor: Ningbo Newbay Technology Development Co., Ltd • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Global effort launches to unlock secrets of rare digestive cancer
Knowledge-focused Not yet recruitingThis is a registry study that aims to collect medical information and samples from 1,000 people diagnosed with a rare digestive tract tumor called GIST. It does not test new treatments but gathers data to help researchers better understand how the disease behaves, especially in r…
Matched conditions: GIST - GASTROINTESTINAL STROMAL TUMOR
Sponsor: Universität Duisburg-Essen • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC